BENJAMIN MARSHALL: Open Payments
NPI 1003512856 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 52 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $230 |
| Merck Sharp & Dohme LLC | 6 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $141 |
| Regeneron Healthcare Solutions, Inc. | 5 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| GENZYME CORPORATION | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Verona Pharma, Inc. | 2 | $42 |
| JAZZ PHARMACEUTICALS INC. | 1 | $36 |
Products named: DUPIXENT, VERQUVO, CAPLYTA, AIRSUPRA, Kerendia, TEZSPIRE, JARDIANCE, Ohtuvayre.
Industry payments across MI — which companies pay providers there.
